CLASS III ONGOING Drug recall · Reported 27 May 2026 · FDA Enforcement Report

Primidone Tablets, USP, 50 mg ( unit dose blister) recalled

Amerisource Health Services is recalling Primidone Tablets, USP, 50 mg ( unit dose blister) per, distributed nationwide in the US. The recall was initiated on 1 May 2026 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot 1028739, exp 12/31/2027; Lot 1025622, exp 06/30/2027
NDC68084-202, 68084-203
Quantity recalled225,000 tablets

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0537-2026
FDA event ID
98884
Recalling firm
Amerisource Health Services, Columbus, OH
Manufacturer
American Health Packaging
Classification
Class III
Status
Ongoing
Recall initiated
1 May 2026
FDA classified
18 May 2026
Reported
27 May 2026
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Packaging Defects

Timeline

1 May 2026Recall initiated by company
18 May 2026Classified by FDA+17 days
27 May 2026Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Cross contamination with other products: API contaminated with trace amounts of Acemetacin API.

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

Primidone Tablets, USP, 50 mg, 100 Tablets (10 x 10 unit dose blister) per carton, Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217. Carton NDC: 68084-202-01; Individual Dose NDC: 68084-202-11

Where it was distributed

USA Nationwide

Nationwide

Questions about this recall

Is Primidone Tablets, USP, 50 mg ( unit dose blister) per recalled?

Yes. Amerisource Health Services recalled Primidone Tablets, USP, 50 mg ( unit dose blister) per on 1 May 2026. The recall is Class III and its status is Ongoing. Recall number D-0537-2026.

Why was it recalled?

Cross contamination with other products: API contaminated with trace amounts of Acemetacin API.

Which lots are affected?

Lot 1028739, exp 12/31/2027; Lot 1025622, exp 06/30/2027

Where was it sold?

USA Nationwide

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Amerisource Health Services

All 69

Other Primidone recalls

All 6